From HPV to COVID-19 and beyond: leveraging the power of serology and standards

Lancet Microbe. 2023 Dec;4(12):e966-e967. doi: 10.1016/S2666-5247(23)00287-2. Epub 2023 Sep 28.

Authors

Heidi A Hempel¹, Troy J Kemp¹, Nancy Roche¹, Ligia A Pinto²

Affiliations

¹ Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
² Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA. Electronic address: pintol@mail.nih.gov.

PMID: 37778361
DOI: 10.1016/S2666-5247(23)00287-2

No abstract available

MeSH terms

Antibodies, Viral
COVID-19*
Hematologic Tests
Humans
Papillomavirus Infections* / epidemiology
Reference Standards

Substances

Antibodies, Viral